E. Di Salle

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

Manfred Kaufmann, Emilio Bajetta, Luc Dirix et al. · Journal of Clinical Oncology · 2000 · 525 citations

Medicine, Oncology, Pharmacology +14

Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial

Per Eystein Lønning, Emilio Bajetta, Robin Murray et al. · Journal of Clinical Oncology · 2000 · 318 citations

Medicine, Oncology, Pharmacology +16

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Jürgen Geisler, Nicholas King, Gun Anker et al. · PubMed · 1998 · 316 citations

Medicine, Endocrinology, Pharmacology +17

Biochemical and pharmacogenetic dissection of human steroid 5??-reductase type II

Nick Makridakis, E. Di Salle, Juergen Reichardt · Pharmacogenetics · 2000 · 211 citations

Life Sciences, Biochemistry, Pharmacology +17

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

Dag Clement Johannessen, Terje Engan, E. Di Salle et al. · PubMed · 1997 · 193 citations

Medicine, Endocrinology, Pharmacology +17